Curative Biosciences, Inc. (OTCPK: CBDX)
Health Care · Pharmaceuticals · US
$—
— today · — 1Y
Curative Biosciences, Inc. (OTCPK: CBDX) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $25.79K and employs 6 people.
trading between 0.00 and 0.00.
Tweenvest scores Curative Biosciences, Inc. across four factors: quality 6/100. Its strongest factor is quality.
CBDX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $25.79K
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.03
- Dividend yield
- —
- Beta (5Y)
- -16.26
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 257.89M
- Employees
- 6
- Next earnings
- —
About Curative Biosciences, Inc.
Curative Biosciences, Inc. focuses on developing and commercializing therapeutics using hemp-derived Cannabidiol. It intends to manufacture and market natural health products and operate in the medical cannabis industry. The company was formerly known as Amaize Beverage Corporation and changed its name to Curative Biosciences, Inc. in August 2017. Curative Biosciences, Inc. was founded in 2009 and is based in Miami, Florida.
- ISIN
- US23127M1018
- Founded
- 2009
- Listed since
- Aug 26, 2004
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,247.82 | +0.07% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $273.26 | +0.08% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $156.29 | +3.74% |
| Roche Holding AGSWX: ROP | $368.80B | CHF373.80 | +0.92% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £124.76 | +3.02% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $28.41 | +1.56% |
Figures last refreshed Aug 18, 2026.